New research indicates that individuals who come off popular GLP-1 drugs like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who stop conventional diet and exercise programs.
Findings released in a major health publication points out that while overweight people frequently drop substantial amounts of their body weight while on the medication, the mass comes back at an average rate of nearly a kilo each month once they quit.
"Users buying these treatments need to be aware of the potential of fast rebound weight gain when the medication is stopped," stated expert Dr. Susan Jebb.
This pace of regain means a reversion to original mass within about a year and a half.
Weighing Treatments
The study, which reviewed 37 of trials involving thousands of patients, contrasted the outcomes of these new drugs with conventional dieting.
The team point out that people who shed pounds through diet and exercise typically have a slower weight regain—perhaps 100 grams monthly—after stopping.
Explaining the Quick Rebound
Nutrition scientists suggest the mode of action of the jabs accounts for the accelerated rebound.
GLP-1 drugs mimic a body's own chemical called GLP-1, which helps regulate appetite.
"Artificially providing GLP-1 levels several times higher than the body's typical production may cause the body to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement leads to appetite is uncontrolled, making overeating far more likely."
A Lifelong Issue?
The NHS suggest the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Professionals argue that, given the significant potential of weight regain, the treatment is often long-term.
This view is supported by pharmaceutical companies, who state that the results "highlight the long-term nature of obesity," similar to managing diseases like high blood pressure.
User Accounts
Users who have discontinued the medication explain a powerful resurgence of cravings.
"I experienced something activating and you're instantly starving," described one woman.
This challenge is compounded if individuals have not developed lasting lifestyle or habit modifications during treatment.
Widespread Adoption
Survey data indicate that a significant number of people in the UK have tried these injections in the last 12 months, with interest remaining high.
- Adoption is higher among females than males.
- The 40s and 50s age group shows the greatest level of interest.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, clinicians caution that while these medications are powerful agents for weight loss, they are not a magic solution and maintained weight loss hinges on ongoing behavioural changes.